Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 USD | 0.00% | -7.23% | +103.97% |
May. 14 | Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours | MT |
May. 14 | Nuvation Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Nuvation Bio Inc.
Upcoming events on Nuvation Bio Inc.
Past events on Nuvation Bio Inc.
2024-05-14 04:05 pm | Q1 2024 Earnings Release |
2024-02-29 04:01 pm | Q4 2023 Earnings Release |
2023-11-02 04:10 pm | Q3 2023 Earnings Release |
2023-08-03 04:10 pm | Q2 2023 Earnings Release |
2023-05-15 11:00 am | Annual General Meeting |
2023-05-04 04:05 pm | Q1 2023 Earnings Release |
2023-03-15 04:05 pm | Q4 2022 Earnings Release |
2022-11-03 04:05 pm | Q3 2022 Earnings Release |
2022-08-04 04:05 pm | Interim 2022 Earnings Release |
2022-05-16 10:00 am | Annual General Meeting |
2022-05-09 04:05 pm | Q1 2022 Earnings Release |
2022-02-28 04:05 pm | FY 2021 Earnings Release |
2022-01-11 07:30 am | JP Morgan Healthcare Conference |
2021-11-10 04:05 pm | Q3 2021 Earnings Release |
2021-08-12 04:05 pm | Interim 2021 Earnings Release |
2021-08-09 | Wedbush Pacgrow Healthcare Conference |
2021-06-02 09:00 am | Jefferies Healthcare Conference |
2021-05-17 05:00 pm | Q1 2021 Earnings Release |
2021-03-11 05:15 pm | FY 2020 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -32,1 | -43,6 -40,1 -8.56% | -93,3 -90,1 -3.57% | -120 -123 2.27% | -99,8 -107 6.41% | -101 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -41,7 -38,2 -9.15% | -86,8 -87,0 0.18% | -104 -108 3.31% | -75,8 -84,8 10.62% | -76,5 |
Net income Million USD | Released Forecast Spread | 0,00 | -64,3 -38,2 -68.43% | -86,8 -87,0 0.18% | -104 -108 3.31% | -75,8 -84,8 10.62% | -76,5 |
EPS USD | Released Forecast Spread | -0,16 | -0,23 -0,16 -48.39% | -0,44 -0,43 -1.54% | -0,48 -0,50 3.68% | -0,35 -0,39 9.48% | -0,27 |
Announcement Date | 12/11/20 | 11/03/21 | 28/02/22 | 15/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -28,2 -32,2 12.48% | -37,9 -30,5 -24.09% | -29,3 -32,3 9.19% | -24,3 -27,1 10.23% | -26,5 -24,1 -9.96% | -26,1 -27,6 5.33% | -26,3 -27,4 3.94% | -20,8 -27,7 24.71% | 20,2 -25,2 180.03% | -22,4 | -29,0 | -32,6 | -41,1 | -46,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,3 -30,9 31.03% | -34,9 -28,6 -22.07% | -27,2 -30,5 10.75% | -20,8 -24,8 15.91% | -21,7 -22,1 1.47% | -20,6 -25,5 19.09% | -19,6 -23,8 17.45% | -13,8 -22,8 39.53% | -14,8 -18,7 21.07% | -16,7 | -21,2 | -24,4 | -35,7 | -41,5 |
Net income Million USD | Released Forecast Spread | -21,3 -30,9 31.03% | -34,9 -28,6 -22.07% | -27,2 -30,5 10.75% | -20,8 -24,8 15.91% | -21,7 -22,1 1.47% | -20,6 -25,5 19.09% | -19,6 -23,8 17.45% | -13,8 -22,8 39.53% | -14,8 -18,7 21.07% | -16,7 | -21,2 | -24,4 | -35,7 | -41,5 |
EPS USD | Released Forecast Spread | -0,10 -0,14 30.56% | -0,16 -0,13 -20% | -0,12 -0,14 14.29% | -0,10 -0,12 13.04% | -0,10 -0,10 0% | -0,09 -0,11 19.41% | -0,09 -0,11 18.18% | -0,06 -0,11 42.86% | -0,07 -0,09 17.65% | -0,06 | -0,07 | -0,08 | -0,10 | -0,11 |
Announcement Date | 09/05/22 | 04/08/22 | 03/11/22 | 15/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 29/02/24 | 14/05/24 | - | - | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Nuvation Bio Inc.
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NUVB Stock
- Calendar Nuvation Bio Inc.